The much-awaited Pfizer Inc. and BioNTech SE’s COVID-19 vaccine rolls could pose a challenge to countries as they will be required to ramp up a cold-chain infrastructure for storage, according to Bloomberg. Vaccine shots must be stored at -70 degrees Celsius and must be injected within five days, or it goes bad.
- Countries will need to invest in complex and costly deep-freeze airport warehouses, refrigerated vehicles, and inoculation points.
- Massive investment and coordination required to keep the vaccine in a good state imply that only wealthy nations and perhaps, the urban populations are guaranteed access.
- Refrigeration challenges are a blow to emerging countries, days after Pfizer and BioNTech announced its vaccine candidate is 90% effective from a Phase 3 clinical study.
Traders keep focus on U.S. equities in the medical equipment sector. IHI (iShares U.S. Medical Devices ETF) has $8.8 billion in AUM, as of November 10, 2020. Total return for the ETF in 2019 was 32.72%, and 2020 YTD performance is 20.07%.
IHI is down 1.00%, ABT: NYSE is up on premarket 0.87%, TMO: NYSE is up on premarket 1.54%, MDT: NYSE closed on Tuesday 1.18% higher.